Approximately 20–30% of individuals with RA exhibit a seronegative phenotype, defined by the absence of rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibodies (ACPA) [2,3,4]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.